The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.
Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration announced the approval of a new blood test for colorectal cancer . Shield, made by Guardant Health in California, is the first approved blood test that is considered a primary screening option for the disease and meets Medicare coverage requirements, the company stated.
The FDA’s approval, announced Tuesday, follows a large clinical trial that included 20,000 average-risk adults, which found that Shield had an 83% sensitivity for the detection of CRC. Those findings were published in The New England Journal of Medicine in March.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves Donanemab for Early Alzheimer'sThe FDA has approved the anti-amyloid donanemab for early symptomatic Alzheimer's, which includes MCI or mild dementia stage of disease, with confirmed amyloid pathology.
Read more »
FDA Approves Eli Lilly's New Alzheimer's Drug For Early Disease SymptomsThe Best in Science News and Amazing Breakthroughs
Read more »
FDA approves new blood test to screen for colon cancerThe test showed an accuracy rate of 83 percent in clinical trials and could be a game changer in colon cancer screening, encouraging many more people to get checked for the disease. NBC News' Anne Thompson reports.
Read more »
FDA approves blood test for colon cancerShield is approved as a screening method for those 45 and older who are at average risk for colon cancer, the second-leading cause of cancer-related death in the U.S.
Read more »
FDA approves blood test for colon cancer detectionThe Food and Drug Administration has approved a blood test intended to detect colorectal cancer, expanding options for screening for the potentially deadly disease.
Read more »
FDA approves colon cancer blood test, but some will still need colonoscopiesJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »